Неврология, нейропсихиатрия, психосоматика (Dec 2018)

Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings)

  • V. A. Parfenov,
  • S. A. Zhivolupov,
  • V. V. Zakharov,
  • L. A. Belova,
  • O. V. Lagoda,
  • R. G. Esin,
  • N. V. Vakhnina,
  • I. N. Samartsev

DOI
https://doi.org/10.14412/2074-2711-2018-4-139-145
Journal volume & issue
Vol. 10, no. 4
pp. 139 – 145

Abstract

Read online

The paper presents the proceedings of the Round Table with the participation of leading neurologists, which is devoted to chronic cerebrovascular diseases. It is noted that chronic cerebral ischemia (CCI), or dyscirculatory encephalopathy (DEP), is one of the most common neurological diagnoses in our country. The pathogenesis, clinical presentations, diagnosis and treatment of CCI (DEP) and its matching with vascular cognitive impairment (CI), which is regarded in foreign literature as the main manifestation of chronic cerebrovascular disease (CVD) were considered. The authors analyze clinical trials evaluating the efficacy of vinpocetine (Cavinton) in chronic CVD, dizziness, CI, as well as the use of new vinpocetine formulations, such as Cavinton Comforte, in various neurological diseases, dysphagia in particular, in poststroke patients.

Keywords